80 related articles for article (PubMed ID: 12488323)
1. Tissue inhibitor of metalloproteinase-1 (TIMP-1) deficient mice display reduced serum progesterone levels during corpus luteum development.
Nothnick WB
Endocrinology; 2003 Jan; 144(1):5-8. PubMed ID: 12488323
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the role of tissue inhibitor of metalloproteinase-1 (TIMP-1) during the periovulatory period in female mice lacking a functional TIMP-1 gene.
Nothnick WB; Soloway P; Curry TE
Biol Reprod; 1997 May; 56(5):1181-8. PubMed ID: 9160717
[TBL] [Abstract][Full Text] [Related]
3. MMPS and TIMPS in ovarian physiology and pathophysiology.
Goldman S; Shalev E
Front Biosci; 2004 Sep; 9():2474-83. PubMed ID: 15353300
[TBL] [Abstract][Full Text] [Related]
4. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum.
Liu K; Olofsson JI; Wahlberg P; Ny T
Endocrinology; 1999 Nov; 140(11):5330-8. PubMed ID: 10537164
[TBL] [Abstract][Full Text] [Related]
5. The steroidogenic response and corpus luteum expression of the steroidogenic acute regulatory protein after human chorionic gonadotropin administration at different times in the human luteal phase.
Kohen P; Castro O; Palomino A; Muñoz A; Christenson LK; Sierralta W; Carvallo P; Strauss JF; Devoto L
J Clin Endocrinol Metab; 2003 Jul; 88(7):3421-30. PubMed ID: 12843197
[TBL] [Abstract][Full Text] [Related]
6. The effect of luteal "rescue" on the expression and localization of matrix metalloproteinases and their tissue inhibitors in the human corpus luteum.
Duncan WC; McNeilly AS; Illingworth PJ
J Clin Endocrinol Metab; 1998 Jul; 83(7):2470-8. PubMed ID: 9661630
[TBL] [Abstract][Full Text] [Related]
7. Localization and temporal regulation of tissue inhibitor of metalloproteinases-4 in mouse ovary.
Bu S; Cao C; Yang Y; Miao C; Hu Z; Cao Y; Sang QA; Duan E
Reproduction; 2006 Jun; 131(6):1099-107. PubMed ID: 16735549
[TBL] [Abstract][Full Text] [Related]
8. Caspase-3 is a pivotal mediator of apoptosis during regression of the ovarian corpus luteum.
Carambula SF; Matikainen T; Lynch MP; Flavell RA; Gonçalves PB; Tilly JL; Rueda BR
Endocrinology; 2002 Apr; 143(4):1495-501. PubMed ID: 11897708
[TBL] [Abstract][Full Text] [Related]
9. Hepatic lipase deficiency attenuates mouse ovarian progesterone production leading to decreased ovulation and reduced litter size.
Wade RL; Van Andel RA; Rice SG; Banka CL; Dyer CA
Biol Reprod; 2002 Apr; 66(4):1076-82. PubMed ID: 11906928
[TBL] [Abstract][Full Text] [Related]
10. Steroidal regulation of uterine edema and tissue inhibitors of metalloproteinase (TIMP)-3 messenger RNA expression is altered in TIMP-1-deficient mice.
Nothnick WB; Zhang X; Zhou HE
Biol Reprod; 2004 Feb; 70(2):500-8. PubMed ID: 14568914
[TBL] [Abstract][Full Text] [Related]
11. Differential distribution of gelatinases and tissue inhibitor of metalloproteinase-1 in the rat ovary.
Bagavandoss P
J Endocrinol; 1998 Aug; 158(2):221-8. PubMed ID: 9771466
[TBL] [Abstract][Full Text] [Related]
12. Chronic exposure of the developing corpus luteum in monkeys to chorionic gonadotropin: persistent progesterone production despite desensitization of adenylate cyclase.
Vandevoort CA; Stouffer RL; Molskness TA; Ottobre JS
Endocrinology; 1988 May; 122(5):1876-82. PubMed ID: 2834178
[TBL] [Abstract][Full Text] [Related]
13. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
Jo M; Thomas LE; Wheeler SE; Curry TE
Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the tissue inhibitor of metalloproteinase-1 gene results in altered reproductive cyclicity and uterine morphology in reproductive-age female mice.
Nothnick WB
Biol Reprod; 2000 Sep; 63(3):905-12. PubMed ID: 10952938
[TBL] [Abstract][Full Text] [Related]
15. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin.
Quagliarello J; Goldsmith L; Steinetz B; Lustig DS; Weiss G
J Clin Endocrinol Metab; 1980 Jul; 51(1):74-7. PubMed ID: 7380995
[TBL] [Abstract][Full Text] [Related]
16. Noncoordinated expression of luteal cell messenger ribonucleic acids during human chorionic gonadotropin stimulation of the primate corpus luteum.
Benyo DF; Little-Ihrig L; Zeleznik AJ
Endocrinology; 1993 Aug; 133(2):699-704. PubMed ID: 8344208
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of primate luteal function by recombinant human chorionic gonadotropin and modulation of steroid, but not relaxin, production by an inhibitor of 3 beta-hydroxysteroid dehydrogenase during simulated early pregnancy.
Duffy DM; Hutchison JS; Stewart DR; Stouffer RL
J Clin Endocrinol Metab; 1996 Jun; 81(6):2307-13. PubMed ID: 8964869
[TBL] [Abstract][Full Text] [Related]
18. Ovarian 3 beta-hydroxysteroid dehydrogenase and sulfated glycoprotein-2 gene expression are differentially regulated by the induction of ovulation, pseudopregnancy, and luteolysis in the immature rat.
Kaynard AH; Periman LM; Simard J; Melner MH
Endocrinology; 1992 Apr; 130(4):2192-200. PubMed ID: 1547735
[TBL] [Abstract][Full Text] [Related]
19. Impact of buserelin acetate or hCG administration on day 12 post-ovulation on subsequent luteal profile and conception rate in buffalo (Bubalus bubalis).
Pandey AK; Ghuman SP; Dhaliwal GS; Kumar A; Agarwal SK
Anim Reprod Sci; 2013 Jan; 136(4):260-7. PubMed ID: 23201300
[TBL] [Abstract][Full Text] [Related]
20. Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation.
Hägglund AC; Ny A; Leonardsson G; Ny T
Endocrinology; 1999 Sep; 140(9):4351-8. PubMed ID: 10465309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
